StonvexLoading…
StonvexStonvexStonvexCore line items from INBX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $1.30M | $200.00K | $1.80M |
Operating Income | $-135.03M | $-331.45M | $-219.22M |
Net Income | $-140.06M | $1.69B | $-241.36M |
EPS (Diluted) | $-9.04 | $112.62 | $-20.48 |
Total Assets | $146.48M | $180.77M | $307.89M |
Total Liabilities | $138.49M | $47.18M | $264.39M |
Cash & Equivalents | $124.22M | $152.60M | $277.92M |
Free Cash Flow OCF − CapEx | $-129.82M | $-197.01M | $-197.90M |
Shares Outstanding | 14.58M | 14.48M | 47.37M |